Valion Bio, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.8M | $15.0M | $13.0M |
| FY2022 | $2.2M | $5.9M | $3.5M |
| FY2023 | $1.6M | $5.2M | $3.4M |
| FY2024 | $272.0K | $2.8M | $2.0M |
| FY2025 | $7.4M | $31.6M | $12.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $1.8M | $15.0M | $13.0M |
| FY2022 | $2.2M | $5.9M | $3.5M |
| FY2023 | $1.6M | $5.2M | $3.4M |
| FY2024 | $272.0K | $2.8M | $2.0M |
| FY2025 | $7.4M | $31.6M | $12.6M |